Leigh Baldwin & Co’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$830K Sell
8,022
-179
-2% -$16K 0.45% 50
2026
Q1
$589K Buy
8,201
+32
+0.4% +$2.46K 0.38% 64
2025
Q4
$648K Sell
8,169
-1,003
-11% -$79.1K 0.43% 57
2025
Q3
$691K Sell
9,172
-481
-5% -$33K 0.39% 66
2025
Q2
$666K Buy
9,653
+3,105
+47% +$204K 0.44% 65
2025
Q1
$444K Buy
6,548
+308
+5% +$18.4K 0.36% 76
2024
Q4
$280K Buy
+6,240
New +$350K 0.24% 122

Other funds holding CVS

Leigh Baldwin & Co's CVS Position: Q2 2026 in Review

Leigh Baldwin & Co reduced its CVS Health (CVS) stake by 2.2% in Q2 2026, selling an estimated $16K and leaving 8,022 shares worth $830K. The position accounts for 0.45% of the portfolio, ranked #50.

Leigh Baldwin & Co first reported a position in CVS in Q4 2024 and has held it in 7 quarters since. 2,067 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Leigh Baldwin & Co held 8,022 shares of CVS Health worth $830K as of Q2 2026.
  • Leigh Baldwin & Co sold 179 CVS Health shares in Q2 2026, an estimated $16K.
  • CVS Health made up 0.45% of Leigh Baldwin & Co's portfolio in Q2 2026, its #50 holding.
  • Leigh Baldwin & Co first reported a position in CVS Health in Q4 2024 and has held it in 7 quarters since.
  • 2,067 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Leigh Baldwin & Co's 13F filing for Q2 2026, filed 13 Aug 2026.